Invion Limited

PINK:IVIXF USA Drug Manufacturers - Specialty & Generic
Market Cap
$3.58 Million
Market Cap Rank
#34149 Global
#11132 in USA
Share Price
$0.04
Change (1 day)
+0.00%
52-Week Range
$0.04 - $0.04
All Time High
$3.72
About

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also in… Read more

Invion Limited (IVIXF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: -0.223x

Based on the latest financial reports, Invion Limited (IVIXF) has a cash flow conversion efficiency ratio of -0.223x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-847.52K) by net assets ($3.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Invion Limited - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Invion Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Invion Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Invion Limited ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Invion Limited (2014–2025)

The table below shows the annual cash flow conversion efficiency of Invion Limited from 2014 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $5.43 Million $-1.95 Million -0.360x -224.54%
2024-06-30 $14.44 Million $-1.60 Million -0.111x -12.52%
2023-06-30 $12.25 Million $-1.21 Million -0.099x -73.98%
2022-06-30 $13.51 Million $-765.16K -0.057x -164.92%
2021-06-30 $3.60 Million $313.80K 0.087x +410.95%
2020-06-30 $3.74 Million $-104.97K -0.028x +92.73%
2019-06-30 $3.83 Million $-1.48 Million -0.386x -531.44%
2018-06-30 $5.84 Million $522.43K 0.089x +155.02%
2017-06-30 $1.17 Million $-189.57K -0.163x +85.15%
2016-06-30 $2.61 Million $-2.85 Million -1.094x +25.91%
2015-06-30 $6.86 Million $-10.13 Million -1.477x -244.59%
2014-06-30 $10.16 Million $-4.35 Million -0.429x --